Publikationen in Zusammenarbeit mit Forschern von VU University Amsterdam (12)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

2022

  1. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

    Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  3. Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 12, pp. 4105-4106

2020

  1. Association between DNA methylation and ADHD symptoms from birth to school age: a prospective meta-analysis

    Translational Psychiatry, Vol. 10, Núm. 1

2019

  1. Cellular Senescence: Defining a Path Forward

    Cell, Vol. 179, Núm. 4, pp. 813-827

2014

  1. Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations

    Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736

  2. The application of the Open Pharmacological Concepts Triple Store (Open PHACTS) to support drug discovery research

    PLoS ONE, Vol. 9, Núm. 12

2010

  1. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

    Cell Metabolism, Vol. 12, Núm. 3, pp. 237-249